crwepicks'  Instablog

Send Message
My company:
  • OPTR, PWRM, FHN, MBTF, TECD, - Stock News! Optimer Pharmaceuticals, Power3 Medical Products, First Horizon National Corp., MBT Financial Corp. and Tech Data Corporation 0 comments
    Apr 3, 2011 4:46 PM | about stocks: FHN, MBTF, OPTR, TECD


    optr Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR)

    A Food and Drug Administration advisory panel will evaluate data on the oral drug, fidaxomicin. The medicine would be Optimer’s first product to reach the market if the FDA gives its approval.

    Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (NYSE:CDI). In two Phase 3 trials for the treatment of CDI, fidaxomicin was equally effective in clinical cure when compared to vancomycin, the only FDA approved product for CDI.

    Clostridium difficile is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Illness from the bacterium most commonly affects older adults in hospitals or trin long term care facilities and typically occurs after use of antibiotic medications.( Read More )

    For more information about this company please visit

    Stocks: FHN, MBTF, OPTR, TECD
Back To crwepicks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.